1-6 of 6
Juliana Popa, MD
Close
Save search
Sort by
Journal Articles

Pretreatment Expression Levels of MDR1 and OCT-1 Predict Response to First Line Imatinib Treatment In Chronic Phase CML Patients

Free
Philipp Erben, MD, Benjamin Hanfstein, MD, Umang Munjal, PhD, Hannah Daikeler, MD, Mridul Agrawal, Jr., Juliana Popa, MD, Daniel Nowak, MD, Armin Leitner, MD, Dieter K Hossfeld, MD, Hans J Kolb, MD, Stefan W Krause, MD, Christoph Nerl, MD, Hans Pralle, MD, Dominik Heim, MD, Gabriela M Baerlocher, MD, Jörg Hasford, MD, Hermann Heimpel, MD, Susanne Saussele, MD, Wolf-Karsten Hofmann, MD, Rüdiger Hehlmann, MD, Andreas Hochhaus, MD, Martin C Mueller, MD
Journal: Blood
Blood (2010) 116 (21): 671.
https://doi.org/10.1182/blood.V116.21.671.671
Published: 2010
Journal Articles

KIT D816V and JAK2 V617F Point Mutations Are Recurrently Found In Suspected Hypereosinophilic Syndrome

Free
Juliana Popa, MD, Philipp Erben, MD, Georgia Metzgeroth, MD, Georg Bolz, MD, Martin C Mueller, MD, Christoph Walz, MD, Hans Peter Horny, MD, Philipp Ströbel, MD, Alexander Marx, MD, Nicholas C.P. Cross, PhD, FRCPath, Andreas Hochhaus, Wolf-Karsten Hofmann, MD, Andreas Reiter, MD
Journal: Blood
Blood (2010) 116 (21): 4100.
https://doi.org/10.1182/blood.V116.21.4100.4100
Published: 2010
Journal Articles

Aggressive Systemic Mastocytosis Is Associated with a High Kit D816V Allele Burden in Peripheral Blood.

Free
Philipp Erben, MD, Georg Bolz, MD, Juliana Popa, MD, Georgia Metzgeroth, MD, Martin C Müller, MD, Darko Gosenca, PhD, Thomas Ernst, MD, Wolf-Karsten Hofmann, MD, Andreas Hochhaus, MD, Andreas Reiter, MD
Journal: Blood
Blood (2009) 114 (22): 2899.
https://doi.org/10.1182/blood.V114.22.2899.2899
Published: 2009
Journal Articles

“Clinical and Molecular Heterogeneity of Eosinophilia-Associated Myeloproliferative Neoplasms with a Translocation t(5;12)”.

Free
Darko Gosenca, PhD, Philipp Erben, MD, Claudia Haferlach, MD, Rainer Schwerdtfeger, MD, Herrad Baurmann, Georg Bolz, MD, Juliana Popa, MD, Torsten Haferlach, MD, Wolf-Karsten Hofmann, Andreas Hochhaus, MD, Andreas Reiter, MD
Journal: Blood
Blood (2009) 114 (22): 4983.
https://doi.org/10.1182/blood.V114.22.4983.4983
Published: 2009
Journal Articles

Clinical Phenotype of Myeloproliferative Neoplasms with Activating CBL -mutations Resembles Chronic Myelomonocytic Leukemia.

Free
Juliana Popa, MD, Susanne Schnittger, PhD, Philipp Erben, MD, Tamara Weiss, Ayalew Tefferi, MD, Eva M Kanders, Eva Lengfelder, MD, Martin C. Müller, MD, Torsten Haferlach, MD, Andreas Hochhaus, MD, Wolf-Karsten Hofmann, MD, Andreas Reiter, MD
Journal: Blood
Blood (2009) 114 (22): 3895.
https://doi.org/10.1182/blood.V114.22.3895.3895
Published: 2009
Journal Articles

MDR1 Expression and Pre-Treatment Tumor Load Predict Molecular Response in CML Patients On Nilotinib Therapy After Imatinib Failure.

Free
Mridul Agrawal, Philipp Erben, MD, Benjamin Hanfstein, Hannah Daikeler, MD, Juliana Popa, MD, Thomas Schenk, MD, Armin Leitner, MD, Richard C. Woodman, MD, Andreas Hochhaus, MD, Martin C Müller, MD
Journal: Blood
Blood (2009) 114 (22): 2615.
https://doi.org/10.1182/blood.V114.22.2615.2615
Published: 2009